by HTLV | Sep 10, 2026 | Publications
Epidemiol Serv Saude. 2026 Apr 10;35:e20240668. doi: 10.1590/S2237-96222026v35e20240668.en. eCollection 2026. ABSTRACT OBJECTIVES: To construct and validate an instrument for the notification of cases of human T-cell lymphotropic virus infection. METHODS: This is a...
by HTLV | Sep 10, 2026 | Publications
Epidemiol Serv Saude. 2025 Feb 16;35:e20240799. doi: 10.1590/S2237-96222026v35e20240799.en. eCollection 2026. ABSTRACT OBJECTIVES: To describe the prevalence of human T-lymphotropic virus types 1 and 2 (HTLV-1/2) infection among blood donors at the Mato Grosso Blood...
by HTLV | Sep 10, 2026 | Publications
J Med Virol. 2026 Sep;98(9):e71143. doi: 10.1002/jmv.71143. ABSTRACT Human T‑cell leukemia virus type 1 (HTLV‑1) is a retrovirus that spreads primarily through cell-to-cell transmission. Occupational transmission of HTLV-1 by needlestick injury is considered...
by HTLV | Sep 9, 2026 | Publications
Funct Integr Genomics. 2026 Sep 9;26(1):257. doi: 10.1007/s10142-026-02041-5. ABSTRACT Adult T-cell leukemia/lymphoma (ATLL) and peripheral T-cell lymphomas (PTCLs) are aggressive neoplasms of mature T cells with poor prognosis and limited therapies. ATLL originates...
by HTLV | Sep 9, 2026 | Publications
Int J STD AIDS. 2026 Sep 9:9564624261486905. doi: 10.1177/09564624261486905. Online ahead of print. ABSTRACT BackgroundHuman T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus, mainly transmitted sexually, which causes adult T-cell leukaemia/lymphoma (ATLL) and...
by HTLV | Sep 9, 2026 | Publications
J Med Virol. 2026 Sep;98(9):e71107. doi: 10.1002/jmv.71107. ABSTRACT Human T-lymphotropic virus 1 (HTLV-1) and Human Immunodeficiency Virus 1 (HIV-1) can be transmitted through similar routes, so co-infection may occur, especially in endemic regions. Since there is...
